Fruselac (Spironolactone + Furosemide)
Therapeutic Group : Cardiovascular Presentation: Fruselac Tablet: Each tablet contains Spironolactone USP 50 mg & Furosemide USP 20 mg. Indications: Fruselac is indicated in the treatment of resistant oedema where this is associated with secondary hyperaldosteronism; conditions include chronic congestive heart failure and hepatic cirrhosis. Treatment with Fruselac should be reserved for cases refractory to […]